Showing results (111-120 of 2,025) with videos related to
Sort By:
Pageof 203
Biochemical and Biophysical Research Communications|February 13, 1987
Heterogeneity of beta-adrenoreceptors in guinea pig alveolar type II cellsS K Das, M O Sikpi, P SkolnickEuropean Journal of Pharmacology|September 23, 1986
Effects of beta-carboline-3-carboxylic acid ethyl ester on suppressed and non-suppressed responding in the rhesus monkeyJ R Glowa, P Skolnick, S M PaulBrain, Behavior, and Immunity|March 1, 1989
Suppression of natural killer cell activity by FG 7142, a benzodiazepine receptor "inverse agonist"J M Petitto, P Skolnick, P K AroraJournal of Medicinal Chemistry|January 24, 1992
Synthesis of novel 2-phenyl-2H-pyrazolo[4,3-c]isoquinolin-3-ols: topological comparisons with analogues of 2-phenyl-2,5-dihydropyrazolo[4,3-c]quinolin-3(3H)-ones at benzodiazepine receptorsM S Allen, P Skolnick, J M CookImmunopharmacology|March 1, 1991
Suppression of cytotoxic T lymphocyte (CTL) activity by FG 7142, a benzodiazepine receptor 'inverse agonist'P K Arora, E E Hanna, P SkolnickBrain Research|October 15, 1993
MK-801, but not drugs acting at strychnine-insensitive glycine receptors, attenuate methamphetamine nigrostriatal toxicityR T Layer, L R Bland, P SkolnickPharmacology, Biochemistry, and Behavior|December 1, 1984
Regulation of "peripheral-type" binding sites for benzodiazepines in the pineal glandB A Weissman, P Skolnick, D C KleinNeuropharmacology|May 1, 1984
Absence of intrinsic antagonist actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouseJ N Crawley, P Skolnick, S M PaulPharmacology, Biochemistry, and Behavior|March 1, 1986
Enhancement of brain calcium antagonist binding by phencyclidine and related compoundsG T Bolger, M F Rafferty, P SkolnickAdvances in Experimental Medicine and Biology|January 1, 1990
Hepatic encephalopathy, GABA-ergic neurotransmission and benzodiazepine receptor ligandsE A Jones, A S Basile, P SkolnickPageof 203